Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20027686HPVENSG00000109339.24protein_codingMAPK10NoNo5602A0A286YF97
P53779
Q499Y8
TVIS20027687HPVENSG00000109339.24protein_codingMAPK10NoNo5602A0A286YF97
P53779
Q499Y8
TVIS20027688HPVENSG00000109339.24protein_codingMAPK10NoNo5602A0A286YF97
P53779
Q499Y8
TVIS20027689HPVENSG00000109339.24protein_codingMAPK10NoNo5602A0A286YF97
P53779
Q499Y8
TVIS20027690HPVENSG00000109339.24protein_codingMAPK10NoNo5602A0A286YF97
P53779
Q499Y8
TVIS20027691HPVENSG00000109339.24protein_codingMAPK10NoNo5602A0A286YF97
P53779
Q499Y8
TVIS20027692HPVENSG00000109339.24protein_codingMAPK10NoNo5602A0A286YF97
P53779
Q499Y8
TVIS20027693HPVENSG00000109339.24protein_codingMAPK10NoNo5602A0A286YF97
P53779
Q499Y8
TVIS20027694HPVENSG00000109339.24protein_codingMAPK10NoNo5602A0A286YF97
P53779
Q499Y8
TVIS20027695HPVENSG00000109339.24protein_codingMAPK10NoNo5602A0A286YF97
P53779
Q499Y8
TCGA Plot Options
Drug Information
GeneMAPK10
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0001097
UniProt IDP53779
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830